Suppr超能文献

[匹立酰胺与头孢唑林的沉淀。浓度和pH依赖性研究]

[Precipitation of piritramide and cefazolin. Study of the dependence on concentration and pH].

作者信息

Eckle V-S, Grasshoff C

机构信息

Klinik für Anästhesiologie und Intensivmedizin, Universitätsklinikum Tübingen, Hoppe-Seyler-Str. 3, 72076, Tübingen, Deutschland,

出版信息

Anaesthesist. 2013 Nov;62(11):898-901. doi: 10.1007/s00101-013-2246-y. Epub 2013 Nov 14.

Abstract

BACKGROUND

Drug incompatibility might lead to precipitation with subsequent serious complications, such as transient pulmonary embolism. Recently, incompatibility of the opioid piritramide with cephalosporin antibiotics was described. As both drugs are frequently administered in a perioperative setting, the present study addressed the question whether the precipitation effect depends on the piritramide concentration or on the pH of the solution. Moreover, it was tested whether the precipitate reversibly dissolves in a physiological saline solution.

METHODS

Piritramide was diluted to the final test concentrations in 0.9 % sodium chloride solution. Precipitation tests were performed by combining 1 ml of the respective piritramide dilution with 1 ml of cefazolin (20 mg/ml) in a syringe. Precipitation was detected by visual inspection as an opaque whitish appearance of the mixture. Each concentration was tested 5 times. The pH values of the tested piritramide concentrations were determined using a 3-point calibrated pH meter. The precipitate formed in 1 ml of cefazolin (20 mg/ml) and 1 ml of piritramide (5 mg/ml) was diluted in 3 ml physiological saline.

RESULTS

The piritramide concentrations 5 mg/ml, 3.75 mg/ml and 3 mg/ml precipitated in the presence of cefazolin (20 mg/ml), while the concentrations 1.875 mg/ml, 1 mg/ml and 0.5 mg/ml did not produce a precipitate. To exclude the possibility that changes in pH of the tested dilutions might be responsible for these findings, the pH values of the piritramide dilutions were measured. The mean pH values of the concentrations 5 mg/ml, 3.75 mg/ml, 3 mg/ml, 1.875 mg/ml and 1 mg/ml did not differ significantly (pH 3.89 ± 0.004, n = 26, tested by ANOVA). However, the mean pH of 0.5 mg/ml was significantly different from the other tested dilutions (pH 3.98 ± 0.02, n = 6; p < 0.01 by ANOVA). After diluting the precipitate of piritramide and cefazolin in physiological saline the whitish precipitate completely dissolved and the resulting solution became clear (n = 5).

CONCLUSION

The results imply a concentration dependence of the precipitation with cefazolin, while a correlation with pH changes could not be detected. In cases of co-administration of cephalosporins and piritramide, a piritramide concentration of 1 mg/ml seems to be safe and does not form a precipitate. As the precipitate could be reversed by diluting in saline solution it is most likely that a proton switch between the carboxylic acid moiety of cefazolin and the amino group of piritramide causes the precipitation.

摘要

背景

药物不相容性可能导致沉淀,并引发随后的严重并发症,如短暂性肺栓塞。最近,已报道了阿片类药物匹利卡明与头孢菌素抗生素不相容。由于这两种药物常在围手术期使用,本研究探讨了沉淀效应是取决于匹利卡明浓度还是溶液的pH值。此外,还测试了沉淀物是否能在生理盐溶液中可逆溶解。

方法

将匹利卡明在0.9%氯化钠溶液中稀释至最终测试浓度。沉淀试验通过在注射器中将1 ml相应的匹利卡明稀释液与1 ml头孢唑林(20 mg/ml)混合进行。通过目视检查混合物是否出现不透明的白色外观来检测沉淀。每个浓度测试5次。使用三点校准的pH计测定测试的匹利卡明浓度的pH值。将在1 ml头孢唑林(20 mg/ml)和1 ml匹利卡明(5 mg/ml)中形成的沉淀稀释于3 ml生理盐水中。

结果

在头孢唑林(20 mg/ml)存在的情况下,匹利卡明浓度为5 mg/ml、3.75 mg/ml和3 mg/ml时会产生沉淀,而浓度为1.875 mg/ml、1 mg/ml和0.5 mg/ml时不会产生沉淀。为排除测试稀释液pH值变化可能导致这些结果的可能性,测量了匹利卡明稀释液的pH值。5 mg/ml、3.75 mg/ml、3 mg/ml、1.875 mg/ml和1 mg/ml浓度的平均pH值无显著差异(pH 3.89±0.004,n = 26,经方差分析)。然而,0.5 mg/ml的平均pH值与其他测试稀释液显著不同(pH 3.98±0.02,n = 6;经方差分析p < 0.01)。将匹利卡明和头孢唑林的沉淀物在生理盐水中稀释后,白色沉淀完全溶解,所得溶液变清(n = 5)。

结论

结果表明与头孢唑林的沉淀存在浓度依赖性,而未检测到与pH值变化的相关性。在联合使用头孢菌素和匹利卡明的情况下,匹利卡明浓度为1 mg/ml似乎是安全的,不会形成沉淀。由于沉淀可通过在盐溶液中稀释而逆转,很可能是头孢唑林的羧酸部分与匹利卡明的氨基之间的质子交换导致了沉淀。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验